CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia

Introduction: The ETV6-RUNX1 is a fusion gene associated with a good outcome in B-cell precursor lymphoblastic leukemia. Objective: This study aimed to re-evaluate the CD9 cellular expression by flow cytometry (FC) as a possible tool to predict the presence of ETV6-RUNX1. Method: Childhood B-cell pr...

Full description

Bibliographic Details
Main Authors: Caroline B. Blunck, Eugênia Terra-Granado, Elda P. Noronha, Gabriel Wajnberg, Fábio Passetti, Maria S. Pombo-de-Oliveira, Mariana Emerenciano
Format: Article
Language:English
Published: Elsevier 2019-07-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137919300318
_version_ 1818889316851515392
author Caroline B. Blunck
Eugênia Terra-Granado
Elda P. Noronha
Gabriel Wajnberg
Fábio Passetti
Maria S. Pombo-de-Oliveira
Mariana Emerenciano
author_facet Caroline B. Blunck
Eugênia Terra-Granado
Elda P. Noronha
Gabriel Wajnberg
Fábio Passetti
Maria S. Pombo-de-Oliveira
Mariana Emerenciano
author_sort Caroline B. Blunck
collection DOAJ
description Introduction: The ETV6-RUNX1 is a fusion gene associated with a good outcome in B-cell precursor lymphoblastic leukemia. Objective: This study aimed to re-evaluate the CD9 cellular expression by flow cytometry (FC) as a possible tool to predict the presence of ETV6-RUNX1. Method: Childhood B-cell precursor lymphoblastic leukemia cases were included (n = 186). The percentage of CD9-labeled cells and the median fluorescence intensity ratio were used for correlation with the molecular tests. Receiver Operating Characteristic curves were performed to determine the likelihood of the CD9 expression predicting ETV6-RUNX1. Results: The ETV6-RUNX1 was found in 44/186 (23.6%) cases. Data analysis revealed that the best cutoff for CD9 percentage was 64%, with an accuracy of 0.84, whereas the best cutoff for CD9 median fluorescence intensity ratio was 12.52, with an accuracy of 0.80. A strong association was observed between the level of CD9 expression and the presence of ETV6-RUNX1. Conclusion: These data confirm that the CD9 expression could be used for risk stratification in clinical practice. Keywords: Acute lymphoblastic leukemia, Biomarker, CD9, ETV6-RUNX1, Flow cytometry
first_indexed 2024-12-19T17:07:05Z
format Article
id doaj.art-485a930cff6f4a1c83354f01835a6f36
institution Directory Open Access Journal
issn 2531-1379
language English
last_indexed 2024-12-19T17:07:05Z
publishDate 2019-07-01
publisher Elsevier
record_format Article
series Hematology, Transfusion and Cell Therapy
spelling doaj.art-485a930cff6f4a1c83354f01835a6f362022-12-21T20:13:07ZengElsevierHematology, Transfusion and Cell Therapy2531-13792019-07-01413205211CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemiaCaroline B. Blunck0Eugênia Terra-Granado1Elda P. Noronha2Gabriel Wajnberg3Fábio Passetti4Maria S. Pombo-de-Oliveira5Mariana Emerenciano6Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, BrazilInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, BrazilInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, BrazilInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil; Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil; Atlantic Cancer Research Institute, Moncton, CanadaInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil; Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, BrazilInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, BrazilInstituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil; Corresponding author at: Research Center, Instituto Nacional de Câncer (INCA), Rua André Cavalcanti, 37, Rio de Janeiro CEP: 20231-050, RJ, Brazil.Introduction: The ETV6-RUNX1 is a fusion gene associated with a good outcome in B-cell precursor lymphoblastic leukemia. Objective: This study aimed to re-evaluate the CD9 cellular expression by flow cytometry (FC) as a possible tool to predict the presence of ETV6-RUNX1. Method: Childhood B-cell precursor lymphoblastic leukemia cases were included (n = 186). The percentage of CD9-labeled cells and the median fluorescence intensity ratio were used for correlation with the molecular tests. Receiver Operating Characteristic curves were performed to determine the likelihood of the CD9 expression predicting ETV6-RUNX1. Results: The ETV6-RUNX1 was found in 44/186 (23.6%) cases. Data analysis revealed that the best cutoff for CD9 percentage was 64%, with an accuracy of 0.84, whereas the best cutoff for CD9 median fluorescence intensity ratio was 12.52, with an accuracy of 0.80. A strong association was observed between the level of CD9 expression and the presence of ETV6-RUNX1. Conclusion: These data confirm that the CD9 expression could be used for risk stratification in clinical practice. Keywords: Acute lymphoblastic leukemia, Biomarker, CD9, ETV6-RUNX1, Flow cytometryhttp://www.sciencedirect.com/science/article/pii/S2531137919300318
spellingShingle Caroline B. Blunck
Eugênia Terra-Granado
Elda P. Noronha
Gabriel Wajnberg
Fábio Passetti
Maria S. Pombo-de-Oliveira
Mariana Emerenciano
CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
Hematology, Transfusion and Cell Therapy
title CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
title_full CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
title_fullStr CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
title_full_unstemmed CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
title_short CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukemia
title_sort cd9 predicts etv6 runx1 in childhood b cell precursor acute lymphoblastic leukemia
url http://www.sciencedirect.com/science/article/pii/S2531137919300318
work_keys_str_mv AT carolinebblunck cd9predictsetv6runx1inchildhoodbcellprecursoracutelymphoblasticleukemia
AT eugeniaterragranado cd9predictsetv6runx1inchildhoodbcellprecursoracutelymphoblasticleukemia
AT eldapnoronha cd9predictsetv6runx1inchildhoodbcellprecursoracutelymphoblasticleukemia
AT gabrielwajnberg cd9predictsetv6runx1inchildhoodbcellprecursoracutelymphoblasticleukemia
AT fabiopassetti cd9predictsetv6runx1inchildhoodbcellprecursoracutelymphoblasticleukemia
AT mariaspombodeoliveira cd9predictsetv6runx1inchildhoodbcellprecursoracutelymphoblasticleukemia
AT marianaemerenciano cd9predictsetv6runx1inchildhoodbcellprecursoracutelymphoblasticleukemia